Jacobson Pharma

Jacobson is a leading pharmaceutical company in Hong Kong vertically integrated in the research, development, production, sale and distribution of generic drugs and proprietary medicines with a dedicated team of over 1800 employees.
Jacobson Pharma stock price chart
vol.
change
P/E
Net profit
P/B
Book value
Debts
Net debt
Yield
Growth potential

Jacobson Pharma balance sheet

Report period2019 2020 2021 2022 2023 Q2 24
End date of the reporting period
Capitalization, HK$
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Jacobson Pharma cash flows

Report period2018 2019 2020 2021 2022 2023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Jacobson Pharma multipliers

Report period2019 2020 2021 2022 2023 Q2 24 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Jacobson Pharma profitability

Report period2018 2019 2020 2021 2022 2023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Jacobson Pharma assets
Jacobson Pharma cash flows
Jacobson Pharma dividends
0%

Jacobson Pharma dividend policy

The company pays dividends once every six months

Jacobson Pharma shares

TickerNameTypeNominal valueISINPrice
2633:HKJacobson PharmaCommon share-KYG677291067HK$0.59
Jacobson Pharma news
30.06.2022
Jacobson Pharma's IFRS net income for fiscal 2022 was HK$187.705 million, up 0.7% from HK$186.308 million in the previous year. Revenue increased 10.3% to HK$1.595 billion versus HK$1.446 billion a year earlier.
Source: {source} pictogram www1.hkexnews.hk
Pictogram next
30.06.2022
The Jacobson Pharma Board of Directors announced a quarterly dividend of HK$0.0268 per share. The last day to buy securities to receive the dividend is October 5, 2022. The annual dividend yield may reach 6.64%.
Source: {source} pictogram www1.hkexnews.hk
Pictogram next
26.11.2021
The Jacobson Pharma Board of Directors announced a semi-annual dividend of HK$0.012 per share. The last day to buy securities to receive the dividend is December 8, 2021. The annual dividend yield may reach 4.73%.
Source: {source} pictogram www1.hkexnews.hk
Pictogram next
26.11.2021
Jacobson Pharma's IFRS net income for 6M 2022 fiscal year was HK$82.859 million, down 26.3% from HK$112.453 million in the previous year. Revenue increased 7.9% to HK$750.413 million from HK$695.425 million a year earlier.
Source: {source} pictogram www1.hkexnews.hk
Pictogram next
All Jacobson Pharma news
General information
Company nameJacobson Pharma
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Websitewww.jacobsonpharma.com